(Q81791444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

diffuse large B-cell lymphoma

12 January 2020

main subject

1 reference

13

James O Armitage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

4

Wing C Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

12

Julie M Vose

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Dennis D Weisenburger

2

object named as

Dennis D Weisenburger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

3

Timothy C Greiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

7

Zenggang Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

5

Patricia Aoun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

11

Philip J Bierman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Robert Gregory Bociek

10

object named as

Robert Gregory Bociek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Christine P Hans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Gregory T Cochran

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Lynette M Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

James C Lynch

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1377-1384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15920548%20AND%20SRC:MED&resulttype=core&format=json

Diffuse large cell lymphoma

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Cyclin D3 Expression in Non-Hodgkin Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Expression of cyclin D2 and D3 in lymphoid lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Tissue and cellular distribution of the extended family of protein kinase C isoenzymes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800434

7 January 2021